Skip to main content
. 2015 Sep 9;36(12):4972–4985. doi: 10.1002/hbm.22991

Table 1.

Demographic, clinical, and pathological information

Variables Values Variables Values
Age (yrs) WHO tumor grading, Histologic type—no. (%)
Mean ± std 41.8 ± 12.7 I, dysembryoplastic neuroepithelial tumor 1 (1.5)
Range 19–76 II, astrocytoma 30 (45.4)
Males—no. (%) 43 (65.2) II, oligodendroglioma 9 (13.6)
Right‐handed (%) 66 (100) II, oligoastrocytoma 4 (6.1)
Educational level (yr) 11.9 ± 3.6 III, anaplastic astrocytoma 4(6.1)
MMSE (tot. = 30) 26.6 ± 2.6 III, anaplastic oligodendroglioma 2 (3.0)
Presurgical language function score IV, glioblastoma multiforme 16 (24.2)
Spontaneous speech (tot. = 20) 19.3 ± 1.6 Tumor volume (cm3)
Repetition (tot. = 100) 94.1 ± 11.1 Mean ± std 57.1 ± 33.2
Naming (tot. = 100) 93.2 ± 9.2 Range 4.3–146.1
Comprehension (tot. = 230) 216.1 ± 19.4 Gross total resection—no./tot. no. (%)
Aphasia quotient (AQ)a 94.84b All grades 44/66 (66.7)
Symptoms at presentation—no. (%) I/II 26/44 (59.1)
Seizure 38 (57.6) III/IV 18/22 (81.8)
Headache 15 (22.7) Functional outcome—no. (%)c
Language deficit 9 (13.6) 1 month 12 (18.2)
Others 4 (6.1) 6 month 3 (4.5)

WHO, World Health Organization.

aAQ was calculated according to the method in Western Aphasia Battery (Kertesz and Poole, 1974), AQ = (S+R/10+N/10+C/23)*2.

bA score of 93.8 is usually treated as the cut‐off between aphasia and non‐aphasia.

cNew or increased postoperative language deficits, e.g., aphasia, anomia.